EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RNases: Critical Regulators From Cellular Guardian to Tumor Progression and Drug Resistance

Zikun Lin, Yunhan Chen, Kuinyu Lee, Mengxin Liu, Zengbin Wang

Cancer Bioscience · 2026

DOI: 10.1016/j.cbs.2026.100015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Bioscience, 2026. Verfasst von Zikun Lin und 4 weiteren Autor:innen. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating challenge of tumor resistance has brought dysregulation of RNA metabolic homeostasis into focus as a critical driver of malignancy. This review delineates a profound paradigm shift in the ribonuclease (RNase) superfamily, moving beyond their traditional roles as passive housekeeping enzymes to establish them as active regulators in tumor biology. We systematically analyze the core mechanisms underlying this functional transition: the RNase A family orchestrates tumor invasion and metabolic reprogramming; the RNase III family, as the core machinery for miRNA biogenesis, governs tumor stemness, immune evasion, and multidrug resistance; the RNase H family exhibits a dual role, maintaining genomic stability while paradoxically facilitating immune evasion; and emerging members, such as RNase T2, extensively remodel the tumor microenvironment and subvert host immune defenses. Furthermore, we explore the clinical potential of RNases as dynamic biomarkers across the treatment continuum and discuss next-generation translational strategies, including protein degraders and combinations with immune checkpoint inhibitors or targeted agents. Deciphering the multidimensional regulatory networks governed by RNases may unlock novel therapeutic avenues for overcoming highly heterogeneous malignancies.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Lin, Z., Chen, Y., Lee, K., Liu, M., & Wang, Z. (2026). RNases: Critical Regulators From Cellular Guardian to Tumor Progression and Drug Resistance. Cancer Bioscience. https://doi.org/10.1016/j.cbs.2026.100015

Vancouver

Lin Z, Chen Y, Lee K, Liu M, Wang Z. RNases: Critical Regulators From Cellular Guardian to Tumor Progression and Drug Resistance. Cancer Bioscience. 2026. doi:10.1016/j.cbs.2026.100015

BibTeX
@article{Lin2026,
  author = {Lin, Zikun and Chen, Yunhan and Lee, Kuinyu and Liu, Mengxin and Wang, Zengbin},
  title = {RNases: Critical Regulators From Cellular Guardian to Tumor Progression and Drug Resistance},
  journal = {Cancer Bioscience},
  year = {2026},
  doi = {10.1016/j.cbs.2026.100015}
}
Kostenlos starten →